Tag: Prescription Drugs
No Significant Weight Change With Adjuvant Sulfonylureas
Addition maintains glycemic control without weight change among patients with T2DM taking metformin
Prescription Drug Monitoring Programs Cut Opioid Use
Reduction in rate of prescribing of Schedule II opioids seen immediately after program launch
ASCO: Adding Daratumumab Early in Myeloma Treatment Efficacious
Response rate doubled for patients with relapsed or refractory multiple myeloma
ASCO: Immunotherapy Beneficial in Advanced Bladder Cancer
About a quarter of older patients deemed too frail for chemo responded to atezolizumab
ASCO: IMAB362 Can Lengthen Lives of Gastric Cancer Patients
Patients with advanced disease lived longer when they received this targeted treatment
ASCO: Extension of Aromatase Inhibitor Tx Benefits Breast CA
Extension of aromatase inhibitor treatment to 10 years linked to higher rates of disease-free survival
Serious Bleeding Risks Linked to OTC Antacids Containing Aspirin
Alka Seltzer, Bromo Seltzer among over-the-counter products vulnerable patients should avoid, FDA says
Spironolactone No Benefit for Knee OA in Older Adults
No improvements seen in symptoms, physical function, or health-related quality of life
Contraindication to Antiplatelet Rx for ~18 Percent With PCI
Six percent of these patients receive antiplatelets; no increased mortality with contraindicated med use
Meds to Treat Opioid Addiction Significantly Underused
In 2013, just 17 percent were given medications like naltrexone after hospital discharge
